10x Genomics (MEX:TXG) Marketable Securities: MXN894 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:TXG 10x Genomics Inc MEX:TXG
58 GF Score
Price MXN335.54
GF Value MXN136.69
! 8 Warning Signs
View Full Analysis

What is 10x Genomics Marketable Securities?

10x Genomics MEX:TXG 58 Marketable Securities is MXN894 Mil as of Mar. 2026. GuruFocus rates MEX:TXG with a GF Score™ of 58/100 and a GF Value™ of MXN136.69. The stock has 8 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. 10x Genomics's Marketable Securities for the quarter that ended in Mar. 2026 was MXN894 Mil.

10x Genomics's annual Marketable Securities increased from Dec. 2023 (MXN499 Mil) to Dec. 2024 (MXN1,029 Mil) but then declined from Dec. 2024 (MXN1,029 Mil) to Dec. 2025 (MXN890 Mil).

10x Genomics  (MEX:TXG) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

10x Genomics Marketable Securities Related Terms

10x Genomics Marketable Securities Historical Data

* Premium members only.

The historical data trend for 10x Genomics's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

10x Genomics Marketable Securities Chart

10x Genomics Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Marketable Securities
Get a 7-Day Free Trial Premium Member Only 0.00 4,098.80 499.23 1,028.92 890.26

10x Genomics Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,019.72 932.97 909.43 890.26 893.76
MEX:TXG
58GF Score
10x Genomics Inc MEX:TXG
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

10x Genomics Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of MXN894 Mil mean?
10x Genomics (MEX:TXG) has a Marketable Securities of MXN894 Mil as of Mar. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on 10x Genomics and its competitors.
Is 10x Genomics' Marketable Securities too high?
10x Genomics' current Marketable Securities is MXN894 Mil. Overall, 10x Genomics has a GF Score™ of 58/100, reflecting its overall financial health beyond just this single metric.
How does 10x Genomics' Marketable Securities compare to HNGE and WAY?
10x Genomics' Marketable Securities of MXN894 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Healthcare Providers & Services company?
A good Marketable Securities depends on the Healthcare Providers & Services industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on 10x Genomics and its competitors. 10x Genomics's current Marketable Securities is MXN894 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is 10x Genomics stock overvalued right now?
10x Genomics (MEX:TXG) has a current Marketable Securities of MXN894 Mil. The stock's GF Value™ is MXN136.69, compared to a current price of MXN335.54 — trading 145.5% above its estimated fair value. The current Marketable Securities is MXN894 Mil. 10x Genomics' overall GF Score™ is 58/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For 10x Genomics (MEX:TXG), the current Marketable Securities is MXN894 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is 10x Genomics (MEX:TXG) Overvalued in 2026?

Based on GuruFocus' analysis, 10x Genomics stock appears to be overvalued. The current stock price of MXN335.54 is trading 145.5% above its estimated GF Value™ of MXN136.69.

Key valuation signals for MEX:TXG:

  • Marketable Securities: MXN894 Mil
  • GF Value™: MXN136.69 vs. price of MXN335.54 (145.5% above fair value)
  • GF Score™: 58/100 with 8 warning signs

No single metric tells the full story. See the MEX:TXG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

10x Genomics Business Description

Other Exchanges TXG:USA0A88:UK1KJ:Germany
Address 6230 Stoneridge Mall Road, Pleasanton, CA, USA, 94588
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives operates from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).
58GF Score

Get the complete analysis for MEX:TXG

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN335.54
Price
MXN136.69
GF Value